Dynamin 2, cell trafficking, and the triple-negative paradox

Oncotarget. 2019 Mar 22;10(24):2336-2337. doi: 10.18632/oncotarget.26778.

Authors

Sophia B Chernikova¹, John C Game¹, J Martin Brown¹

Affiliation

¹ Stanford University, Department of Neurosurgery, Stanford, CA, USA.

No abstract available

Keywords: breast cancer; dynamin 2; homologous recombination; triple-negative.

Publication types

Editorial